Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of …
Over the last 12 months, insiders at Omega Therapeutics, Inc. have bought $0 and sold $0 worth of Omega Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Omega Therapeutics, Inc. have bought $28.12M and sold $220,000 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,323,310 shares for transaction amount of $19.21M was made by Flagship Pioneering Inc. (10 percent owner) on 2023‑02‑27.
2023-06-02 | Sale | director | 5,000 0.0098% | $8.00 | $40,000 | -59.06% | ||
2023-05-01 | Sale | director | 5,000 0.0097% | $8.00 | $40,000 | -56.17% | ||
2023-04-06 | Sale | director | 5,000 0.0102% | $8.00 | $40,000 | -52.52% | ||
2023-03-17 | Sale | director | 10,000 0.0162% | $8.00 | $80,000 | -60.53% | ||
2023-02-27 | 10 percent owner | 3.32M 6.508% | $5.78 | $19.21M | -31.56% | |||
2023-01-10 | Sale | director | 20,000 0.0383% | $8.00 | $160,000 | -36.67% | ||
2022-09-14 | Sale | director | 10,000 0.0251% | $8.00 | $80,000 | -7.14% | ||
2021-08-03 | 10 percent owner | 1.18M 3.7637% | $17.00 | $20M | -32.01% | |||
2021-08-03 | 10 percent owner | 875,000 2.7992% | $17.00 | $14.88M | -32.01% | |||
2021-08-03 | director | 53,082 0.1698% | $17.00 | $902,394 | -32.01% | |||
2021-08-03 | Chief Financial Officer | 2,941 0.0094% | $17.00 | $49,997 | -32.01% | |||
2021-07-30 | 10 percent owner | 75,000 0.2342% | $16.14 | $1.21M | -29.19% |
Flagship Pioneering Inc. | 10 percent owner | 7508693 13.6138% | $1.10 | 2 | 0 | <0.0001% |
Invus Public Equities, L.P. | 10 percent owner | 2273530 4.1221% | $1.10 | 2 | 0 | <0.0001% |
BERRY DAVID A | director | 53082 0.0962% | $1.10 | 1 | 0 | <0.0001% |
Sawhney Roger | Chief Financial Officer | 2941 0.0053% | $1.10 | 1 | 0 | <0.0001% |
Flagship Pioneering | $106.67M | 52.99 | 29.23M | 0% | +$0 | 7 | |
Fidelity Investments | $22.97M | 11.41 | 6.29M | +19.04% | +$3.67M | <0.01 | |
HarbourVest Partners | $12.82M | 6.37 | 3.51M | 0% | +$0 | 5.85 | |
State of Wisconsin Investment Board | $6.78M | 3.37 | 1.86M | 0% | +$0 | 0.02 | |
BlackRock | $5.17M | 2.57 | 1.42M | +2.4% | +$120,990.22 | <0.0001 |